1-Hydroxybenzotriazole → (S)-3-cyclohexyl-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-2-[2-oxo-4-(2-propyl-phenoxy)-2,5-dihydro-pyrrol-1-yl]-propionamide
Reaction equation
[CH:1]1([CH2:7][C@H:8]([N:12]2[CH2:16][C:15]([O:17][C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=3[CH2:24][CH2:25][CH3:26])=[CH:14][C:13]2=[O:27])[C:9]([OH:11])=O)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.Cl.[CH3:29]N(C)CCCN=C=NCC.C(N(CC)C(C)C)(C)C.ON1C2C=CC=CC=2N=N1.Cl.[OH:60][C@@H:61]([CH2:91]O)[CH2:62][N:63]1[CH:67]=[CH:66][C:65]([NH:68]C(=O)[C@@H](N2CC(OC3C=CC=C(Cl)C=3Cl)=CC2=O)CC(C)C)=[N:64]1>ClCCl.C(OCC)(=O)C>[CH:1]1([CH2:7][C@H:8]([N:12]2[CH2:16][C:15]([O:17][C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=3[CH2:24][CH2:25][CH3:26])=[CH:14][C:13]2=[O:27])[C:9]([NH:68][C:65]2[CH:66]=[CH:67][N:63]([CH2:62][C:61]([OH:60])([CH3:91])[CH3:29])[N:64]=2)=[O:11])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 23 °C
Procedure
To a stirred solution of (S)-3-cyclohexyl-2-[2-oxo-4-(2-propyl-phenoxy)-2,5-dihydro-pyrrol-1-yl]-propionic acid (160 mg, 0.43 mmol) in dichloromethane (12 mL) was gradually added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (230 mg, 1.2 mmol) and N,N-diisopropylethyl amine (260 mg, 2.0 mmol) at room temperature, under nitrogen. After 15 min, 1-hydroxybenzotriazole (184 mg, 1.2 mmol) and 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 63 mg, 0.39 mmol) were added to the reaction mixture. The reaction mixture was then stirred at 23° C. for 48 h. The reaction mixture was diluted with ethyl acetate and washed with a saturated aqueous ammonium chloride solution followed by a saturated aqueous sodium bicarbonate solution. The organic layer was then washed with a saturated aqueous sodium chloride solution, separated, dried over sodium sulfate and concentrated in vacuo to afford the crude product, which was purified by flash column chromatography (silica gel (100-200 mesh)) which afforded (S)-3-cyclohexyl-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-2-[2-oxo-4-(2-propyl-phenoxy)-2,5-dihydro-pyrrol-1-yl]-propionamide (58 mg, 26%) as an off-white solid: 1H NMR (400 MHz, CDCl3) δ ppm 0.90 (t, J=7.3 Hz, 3H), 0.94-1.08 (m, 2H), 1.14 (br. s., 3H), 1.15 (br. s., 3H), 1.17-1.33 (m, 4H), 1.51-1.58 (m, 2H), 1.61-1.79 (m, 5H), 1.83 (d, J=12.7 Hz, 1H), 1.87-1.97 (m, 1H), 2.39-2.63 (m, 2H), 3.61 (br. s., 1H), 3.93 (s, 2H), 4.07 (d, J=17.9 Hz, 1H), 4.26 (d, J=17.9 Hz, 1H), 4.85 (s, 1H), 4.85-4.90 (m, 1H), 6.68 (d, J=2.0 Hz, 1H), 7.09 (d, J=7.8 Hz, 1 H), 7.15-7.23 (m, 3H), 7.29 (d, J=2.0 Hz, 1H), 8.57 (br. s., 1H).
Workup
- customat room temperature
- washwashed with a saturated aqueous ammonium chloride solution
- washThe organic layer was then washed with a saturated aqueous sodium chloride solution
- customseparated
- dry with materialdried over sodium sulfate
- concentrationconcentrated in vacuo
- customto afford the crude product, which
- customwas purified by flash column chromatography (silica gel (100-200 mesh)) which
Sources & evidence
- ORD record
- ord-a4dad71ce3db4a84932e23e9ae401da4
- Source dataset
- uspto-grants-2010_06
- Patent number
- US07741327B2
Reaction notes
Loading…